Fuchs H - Search Results

1

Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer.

Panjideh H, Da Silva Coelho VC, Dernedde J, Bachran C, Förster GJ, Franke J, Fasold P, Fuchs H, Thiel E, Deckert PM. Panjideh H, et al. Among authors: fuchs h. Int J Oncol. 2008 Apr;32(4):925-30. Int J Oncol. 2008. PMID: 18360720

2

Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells.

Heisler I, Sutherland M, Bachran C, Hebestreit P, Schnitger A, Melzig MF, Fuchs H. Heisler I, et al. Among authors: fuchs h. J Control Release. 2005 Aug 18;106(1-2):123-37. doi: 10.1016/j.jconrel.2005.04.006. J Control Release. 2005. PMID: 15935506

3

Influence of protein transduction domains on target-specific chimeric proteins.

Bachran C, Heisler I, Fuchs H, Sutherland M. Bachran C, et al. Among authors: fuchs h. Biochem Biophys Res Commun. 2005 Nov 18;337(2):602-9. doi: 10.1016/j.bbrc.2005.09.095. Epub 2005 Sep 23. Biochem Biophys Res Commun. 2005. PMID: 16199006

4

Enhancement of cytotoxicity of lectins by Saponinum album.

Hebestreit P, Weng A, Bachran C, Fuchs H, Melzig MF. Hebestreit P, et al. Among authors: fuchs h. Toxicon. 2006 Mar;47(3):330-5. doi: 10.1016/j.toxicon.2005.11.011. Epub 2006 Jan 4. Toxicon. 2006. PMID: 16387336

5

The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.

Bachran C, Sutherland M, Heisler I, Hebestreit P, Melzig MF, Fuchs H. Bachran C, et al. Among authors: fuchs h. Exp Biol Med (Maywood). 2006 Apr;231(4):412-20. doi: 10.1177/153537020623100407. Exp Biol Med (Maywood). 2006. PMID: 16565437

6

A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.

Fuchs H, Bachran C, Li T, Heisler I, Dürkop H, Sutherland M. Fuchs H, et al. J Control Release. 2007 Feb 26;117(3):342-50. doi: 10.1016/j.jconrel.2006.11.019. Epub 2006 Nov 28. J Control Release. 2007. PMID: 17207883

7

Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay.

Bachran C, Sutherland M, Bachran D, Fuchs H. Bachran C, et al. Among authors: fuchs h. Clin Chem. 2007 Sep;53(9):1676-83. doi: 10.1373/clinchem.2007.085365. Clin Chem. 2007. PMID: 17712004

8

Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer.

Coelho V, Dernedde J, Petrausch U, Panjideh H, Fuchs H, Menzel C, Dübel S, Keilholz U, Thiel E, Deckert PM. Coelho V, et al. Among authors: fuchs h. Int J Oncol. 2007 Oct;31(4):951-7. Int J Oncol. 2007. PMID: 17786329

9

A33scFv-green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting.

Petrausch U, Dernedde J, Coelho V, Panjideh H, Frey D, Fuchs H, Thiel E, Deckert PM. Petrausch U, et al. Among authors: fuchs h. Protein Eng Des Sel. 2007 Dec;20(12):583-90. doi: 10.1093/protein/gzm043. Epub 2007 Nov 22. Protein Eng Des Sel. 2007. PMID: 18033820

10

Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells.

Bachran C, Heisler I, Bachran D, Dassler K, Ervens J, Melzig MF, Fuchs H. Bachran C, et al. Among authors: fuchs h. Cancer Biol Ther. 2008 Feb;7(2):237-42. doi: 10.4161/cbt.7.2.5264. Epub 2007 Nov 3. Cancer Biol Ther. 2008. PMID: 18059188 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,507 results

Search Page

Filters